Drugs / Avenova
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04981860 | Aug 2021 → Dec 2025 | bacterial conjunctivitis | University of Miami | Suspended | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Avenova | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04981860 ↗ |
| Known as | AvenovaTM with Neutrox | “AvenovaTM with Neutrox™ (0.01% HOCl)” NCT04981860 ↗ |
| Route | Topical | “One drop of 0.01% Avenova will be administered to the inferior conjunctiva of the left eye” NCT04981860 ↗ |